0
Skip to Content
Maxwell Biosciences
HealthSpan
Pipeline
Technology
News
Team
Careers
Investors
Maxwell Biosciences
HealthSpan
Pipeline
Technology
News
Team
Careers
Investors
HealthSpan
Pipeline
Technology
News
Team
Careers
Investors
Category
  • Press Release 25
  • News 8
  • Interview 5
  • Newsletter 1
  • Podcast 1
Combating Infectious Diseases: Maxwell Biosciences Partners with U.S. Military 
Interview Caroline B 4/11/25 Interview Caroline B 4/11/25

Combating Infectious Diseases: Maxwell Biosciences Partners with U.S. Military 

Discover how Maxwell Biosciences is advancing biodefense with its Claromer™ platform in an exclusive Contract Pharma interview. CEO Joshua McClure discusses U.S. Military partnerships, a $3M MTEC award and innovative therapeutics for infectious diseases like Dengue Fever.

Read More
Longevity.IO Interview with Maxwell CEO Joshua 'Scotch' McClure: How Claromers™ Could Revolutionize Longevity and Fight Infectious Disease
Interview Caroline B 3/25/25 Interview Caroline B 3/25/25

Longevity.IO Interview with Maxwell CEO Joshua 'Scotch' McClure: How Claromers™ Could Revolutionize Longevity and Fight Infectious Disease

Read More
Turning Nature’s Virus Fighters Into Powerful Drugs: Synthetic “Peptoids” to Cure Diseases
Interview Joshua McClure 7/1/21 Interview Joshua McClure 7/1/21

Turning Nature’s Virus Fighters Into Powerful Drugs: Synthetic “Peptoids” to Cure Diseases

Read More
ViewPoints Interview: Maxwell Biosciences’ Dr. Gill Diamond and Joshua McClure Share Insights Novel Peptoids with Potent Antiviral Activity Against HSV-1 and SARS-CoV-2
Interview Guest User 6/7/21 Interview Guest User 6/7/21

ViewPoints Interview: Maxwell Biosciences’ Dr. Gill Diamond and Joshua McClure Share Insights Novel Peptoids with Potent Antiviral Activity Against HSV-1 and SARS-CoV-2

Read More
Stanford Engineering magazine profiles Dr. Annelise Barron: A bioengineer aims to turn nature's virus into powerful drugs
Interview Guest User 6/1/21 Interview Guest User 6/1/21

Stanford Engineering magazine profiles Dr. Annelise Barron: A bioengineer aims to turn nature's virus into powerful drugs

Read More

Maxwell Biosciences, Inc.

Austin, Texas
United States of America

Company

HealthSpan
Pipeline
Technology
Team
Science
News
Careers
Investors

News

Featured
Fighting Neonatal Sepsis in India
Maxwell Biosciences Subsidiary Havih Announces Partnership with the Government of Andhra Pradesh
Havih, a Maxwell Biosciences Subsidiary, Announces Partnership with the Government of Andhra Pradesh
Former US Congressman Dr. Brad Wenstrup Joins Maxwell Board
Maxwell Biosciences Marks Scientist Appreciation Day With Renewed Call to Recognize Scientists

Science

Featured
Maxwell Peptoids Active Against Herpes Simplex 1 (HSV-1)
Next Generation Virucides – Peptoids

Copyright © 2016 - 2025. Maxwell Biosciences and CLAROMER are registered trademarks of Maxwell Biosciences, Inc. All rights reserved.

Unless otherwise stated, the information on this website has not been evaluated by the Food & Drug Administration. As a research organization, we do not diagnose, treat, cure or prevent any illness or disease. Information is shared for educational purposes only. You must consult your doctor before acting on any content on this website, especially if you are pregnant, nursing, taking medication, or have a medical condition. Compounds in our clinical development programs are tested in animals in accordance with federal preclinical requirements. Compounds developed for cosmetics and personal care items are not tested on animals.